PRTA (STOCKS)
Prothena Corporation plc Ordinary Shares
$8.150000
-0.100000 (-1.21%)
Prev close: $8.250000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Gene G. Kinney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $427.20M
- Employees
- 163
- P/E (TTM)
- -2.93
- P/B (TTM)
- 1.40
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.61 | $-0.36 | +0.9653 | +271.69% |
|
Dec 2025 (Q4)
|
$-0.40 | $-0.57 | +0.1700 | +29.82% |
|
Sep 2025 (Q3)
|
$-0.68 | $-0.70 | +0.0209 | +2.98% |
|
Jun 2025 (Q2)
|
$-1.73 | $-1.34 | -0.3874 | -28.85% |
Financial Statements
| Revenues | $57.94M |
| Benefits Costs and Expenses | $164.67M |
| Costs And Expenses | $164.67M |
| Nonoperating Income/Loss | $12.29M |
| Operating Expenses | $176.96M |
| Research and Development | $96.67M |
| Other Operating Expenses | $80.30M |
| Operating Income/Loss | -$119.02M |
| Income/Loss From Continuing Operations After Tax | -$151.18M |
| Income/Loss From Continuing Operations Before Tax | -$106.73M |
| Income Tax Expense/Benefit | $44.44M |
| Interest Income/Expense After Provision For Losses | $12.21M |
| Interest Income/Expense Operating, Net | $12.21M |
| Net Income/Loss | -$151.18M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$151.18M |
| Net Income/Loss Available To Common Stockholders, Basic | -$151.18M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$2.81 |
| Diluted Earnings Per Share | -$2.82 |
| Basic Average Shares | 161,366,000 |
| Diluted Average Shares | 161,767,000 |
| Assets | $349.89M |
| Current Assets | $339.20M |
| Noncurrent Assets | $10.69M |
| Fixed Assets | $1.96M |
| Other Non-current Assets | $8.73M |
| Liabilities | $37.28M |
| Current Liabilities | $32.52M |
| Accounts Payable | $4.30M |
| Wages | $9.53M |
| Other Current Liabilities | $18.69M |
| Noncurrent Liabilities | $4.76M |
| Equity | $312.62M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $312.62M |
| Liabilities And Equity | $349.89M |
| Net Cash Flow From Operating Activities | -$81.34M |
| Net Cash Flow From Operating Activities, Continuing | -$81.34M |
| Net Cash Flow From Investing Activities | -$22.03M |
| Net Cash Flow From Investing Activities, Continuing | -$22.03M |
| Net Cash Flow From Financing Activities | -$7.04M |
| Net Cash Flow From Financing Activities, Continuing | -$7.04M |
| Net Cash Flow | -$110.40M |
| Net Cash Flow, Continuing | -$110.40M |
| Comprehensive Income/Loss | -$151.18M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$151.18M |
| Other Comprehensive Income/Loss | $0.00 |